Vivakor (VIVK) has a profit margin of -108.95%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for VIVK is -108.95% as of June 2026. That compares with -29.87% in the prior-year period — down 264.7% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Vivakor's historical trend and sector peers before judging valuation or financial health.
Over the past year, VIVK's profit margin moved from -29.87% to -108.95% — a 264.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vivakor's valuation or profitability profile.
Against Healthcare companies, VIVK currently prints -108.95% for profit margin, while the sector average sits near 13.89%. That is roughly 884.2% below the sector mean. Large gaps often invite a closer look at Vivakor's growth, margins, and balance sheet.
Profit Margin shows how effectively Vivakor converts resources into returns. At -108.95%, VIVK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -29.87% in the prior-year period — down 264.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting VIVK's profit margin (-108.95%), review year-over-year change from -29.87%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.